Telogen Effluvium: Multimedia

References

1. Sinclair R. Chronic telogen effluvium: a study of 5 patients over 7 years. J Am Acad Dermatol. Feb 2005;52(2 Suppl 1):12-6. [Medline].

2. Whiting DA. Chronic telogen effluvium: increased scalp hair shedding in middle-aged women. J Am Acad Dermatol. Dec 1996;35(6):899-906. [Medline].

3. Headington JT. Telogen effluvium. New concepts and review. Arch Dermatol. Mar 1993;129(3):356-63. [Medline].

4. Hadshiew IM, Foitzik K, Arck PC, Paus R. Burden of hair loss: stress and the underestimated psychosocial impact of telogen effluvium and androgenetic alopecia. J Invest Dermatol. Sep 2004;123(3):455-7. [Medline].

5. Peters EM, Liotiri S, Bodo E, et al. Probing the effects of stress mediators on the human hair follicle: substance P holds central position. Am J Pathol. Dec 2007;171(6):1872-86. [Medline].

6. Barcaui CB, Gonçalves da Silva AM, Sotto MN, Genser B. Stem cell apoptosis in HIV-1 alopecia. J Cutan Pathol. Oct 2006;33(10):667-71. [Medline].

7. Freinkel RK, Freinkel N. Hair growth and alopecia in hypothyroidism. Arch Dermatol. Sep 1972;106(3):349-52. [Medline].

8. Goette DK, Odom RB. Alopecia in crash dieters. JAMA. Jun 14 1976;235(24):2622-3. [Medline].

9. Kantor J, Kessler LJ, Brooks DG, Cotsarelis G. Decreased serum ferritin is associated with alopecia in women. J Invest Dermatol. Nov 2003;121(5):985-8. [Medline].

10. Trost LB, Bergfeld WF, Calogeras E. The diagnosis and treatment of iron deficiency and its potential relationship to hair loss. J Am Acad Dermatol. May 2006;54(5):824-44. [Medline].

11. Brodin MB. Drug-related alopecia. Dermatol Clin. Jul 1987;5(3):571-9. [Medline].

12. Wise RP, Kiminyo KP, Salive ME. Hair loss after routine immunizations. JAMA. Oct 8 1997;278(14):1176-8. [Medline].

13. Katz KA, Cotsarelis G, Gupta R, Seykora JT. Telogen effluvium associated with the dopamine agonist pramipexole in a 55-year-old woman with Parkinson's disease. J Am Acad Dermatol. Nov 2006;55(5 Suppl):S103-4. [Medline].

14. Tosti A, Piraccini BM, van Neste DJ. Telogen effluvium after allergic contact dermatitis of the scalp. Arch Dermatol. Feb 2001;137(2):187-90. [Medline].

15. Sinclair R, Jolley D, Mallari R, Magee J. The reliability of horizontally sectioned scalp biopsies in the diagnosis of chronic diffuse telogen hair loss in women. J Am Acad Dermatol. Aug 2004;51(2):189-99. [Medline].

16. Rebora A, Guarrera M, Baldari M, Vecchio F. Distinguishing androgenetic alopecia from chronic telogen effluvium when associated in the same patient: a simple noninvasive method. Arch Dermatol. Oct 2005;141(10):1243-5. [Medline].

17. Ross EK, Vincenzi C, Tosti A. Videodermoscopy in the evaluation of hair and scalp disorders. J Am Acad Dermatol. Nov 2006;55(5):799-806. [Medline].

18. Camacho F. Alopecias due to telogen effluvium. In: Camacho F, Montagna W, eds. Trichology: Diseases of the Pilosebaceous Follicle. Madrid, Spain: Aula Medica Group; 1993:403-10.

19. Kligman AM. Pathologic dynamics of human hair loss. I. Telogen effuvium. Arch Dermatol. Feb 1961;83:175-98. [Medline].

20. Rushton DH. Management of hair loss in women. Dermatol Clin. Jan 1993;11(1):47-53. [Medline].

21. Rushton DH, Ramsay ID, James KC, Norris MJ, Gilkes JJ. Biochemical and trichological characterization of diffuse alopecia in women. Br J Dermatol. Aug 1990;123(2):187-97. [Medline].

Further Reading

Keywords

telogen effluvium, chronic telogen effluvium, nonscarring alopecia, alopecia, hair loss, acute hair loss, non-scarring alopecia, balding

Contributor Information and Disclosures

Author

Elizabeth CW Hughes, MD, Dermatologist, Group Health Cooperative
Elizabeth CW Hughes, MD is a member of the following medical societies: American Academy of Dermatology and American Medical Association
Disclosure: Nothing to disclose.

Medical Editor

Leonard Sperling, MD, Chair, Professor, Department of Dermatology, Uniformed Services University of the Health Sciences
Leonard Sperling, MD is a member of the following medical societies: American Academy of Dermatology
Disclosure: Nothing to disclose.

Pharmacy Editor

David F Butler, MD, Professor of Dermatology, Texas A&M University College of Medicine; Chair, Department of Dermatology, Director, Dermatology Residency Training Program, Scott and White Clinic
David F Butler, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American Medical Association, American Society for Dermatologic Surgery, American Society for MOHS Surgery, Association of Military Dermatologists, and Phi Beta Kappa
Disclosure: Nothing to disclose.

Managing Editor

Edward F Chan, MD, Clinical Assistant Professor, Department of Dermatology, University of Pennsylvania School of Medicine
Edward F Chan, MD is a member of the following medical societies: American Academy of Dermatology, American Society of Dermatopathology, and Society for Investigative Dermatology
Disclosure: Nothing to disclose.

CME Editor

Catherine Quirk, MD, Clinical Assistant Professor, Department of Dermatology, Brown University
Catherine Quirk, MD is a member of the following medical societies: Alpha Omega Alpha and American Academy of Dermatology
Disclosure: Nothing to disclose.

Chief Editor

Dirk M Elston, MD, Director, Department of Dermatology, Geisinger Medical Center
Dirk M Elston, MD is a member of the following medical societies: American Academy of Dermatology
Disclosure: Nothing to disclose.